Meriden’s Protein Sciences Corp. reports that the U.S. Department of Health and Human Servics has exercised a $51 million contract option giving it access to the company’s capacity to produce millions of doses of anti-flu vaccine in the event of a pandemic. … more

A director of West Haven’s NanoViricides has invested an additional $5 million in the development-stage drug maker, whose pipeline includes treatments for influenza, dengue fever, HIV and herpes … more

Connecticut Innovations has loaned $1.5 million to Perosphere, a Danbury pharmaceutical company developing a drug that reverses the effects of blood-thinners to help doctors manage major bleeding during emergencies or surgeries. … more